Page last updated: 2024-11-01

omeprazole and Besnier-Boeck Disease

omeprazole has been researched along with Besnier-Boeck Disease in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Prednisone was continued with a slow taper, and after 1 month ber dysphagia had resolved and her esophageal manometry was normal."2.39Reversible esophageal motility disorder in a patient with sarcoidosis. ( Criss, DG; Geissinger, BW; Sharkey, MF; Wu, WC, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geissinger, BW1
Sharkey, MF1
Criss, DG1
Wu, WC1

Reviews

1 review available for omeprazole and Besnier-Boeck Disease

ArticleYear
Reversible esophageal motility disorder in a patient with sarcoidosis.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:7

    Topics: Adult; Deglutition Disorders; Drug Therapy, Combination; Esophageal Motility Disorders; Esophagus; F

1996